Mylan Voluntary Globally Recalls 2 Lots of Levoleucovorin (250mg/25ml) Injection Used to Prevent Harmful Effects of Methotrexate

Shots:

• Mylan has recalled two lots of Levoleucovorin (250mg/25ml) injection to the consumer level having a lot number APB032 & APB033 due to presence of foreign particle as copper salt discovered during a 12-month stability testing
• The voluntary recall is done for the lots of Levoleucovorin, distributed between August 2017 to July 2018 in the US and is conducted within the knowledge of the US FDA
• Levoleucovorin (250mg/25ml) is a single-use vial antidote for dihydrofolate reductase by methotrexate and used as a combination therapy with 5-fluorouracil for advanced metastatic colorectal cancer, developed by Alidac Pharmaceuticals

Click here to read full press release/ article | Ref: Mylan | Image: Daily Post India